Director, Precision Oncology Strategy
CurrentBusiness lead for Exact Science's clinical LDT therapy selection portfolio including whole exome, whole transcriptome, and IHC testing.As business lead, I am responsible for defining and executing portfolio strategy, developing long term product roadmaps and financial models, overseeing multiple development programs, and working closely with the lab and commercial organization to achieve business and financial goals.